Tue 22 Apr 97 12:02 David Bloomberg Long-Term Placebo Effect Power of Placebo Lasts for Years April 17, 1997 NEW YORK (Reuters) - One dictionary defines a placebo as "a medicine given merely to humor the patient." Another calls it an "inactive substance given to satisfy a patient's demand for medicine." No matter how you describe them, the power of placebos to convince patients that they feel better has been observed for centuries. Now, a new study has found that the "placebo effect" can last for years. Researchers testing the effectiveness of a new drug used for treating enlarged prostates discovered that patients taking placebos - or fake pills - showed significantly improved symptoms and urinary flow, even after two years of treatment. The Canadian study involved 613 patients with benign prostatic hyperplasia, or BPH, a condition that affects more than 80% of men between the ages of 50 and 60. Nearly half of the group, 303 men, were taking a placebo - a standard practice in drug testing. The other patients with the condition were given the drug Proscar (finasteride), made by Merck & Company. Neither the patients, nor their doctors, knew what treatment they were assigned. For just over two years (25 months), the researchers analyzed the effect of either the drug or placebo therapy on a patient's prostate size, urine flow, symptoms, and adverse drug reactions. Tests showed that patients taking finasteride averaged a 21% reduction in the size of their prostates, while patients on placebo experienced an 8.4% growth. To the researchers' surprise, however, urinary flow in the placebo group improved significantly within the first five months, and remained improved for the duration of the study. "What surprised us most was the durability of the response," said Dr. J. Curtis Nickel, professor of urology at Queen's University, in Kingston, Ontario. "We've always known that this disease responds to placebo. But the previous studies were short -- 12 to 16 weeks, a year. Our study was probably the longest." Although slightly more than 50% of the patients taking placebo showed improvement during the stuy, most also reported side effects. More than 80% reported adverse effects from the "drug" such as nausea, sleepiness, and dizziness. The most common complaints noted were impotence (6.3%) and decreased libido (6.3%). Thirteen percent of patients on placebo reported symptoms so severe that they discontinued treatment. "These results confirm our suspicion that placebo therapy not only works and that the benefits are durable, but also that these benefits are not without potential clinical side effects," said Nickel. Patients with smaller prostate glands did the best on placebo, according to the study, with more than 15% of them showing significant improvement at two years. Men with larger prostate glands showed some initial improvement on placebo, but the effect faded. "At the end of two years, they were no better than they were before," said Nickel. When patients were finally told what treatment they were on, those on placebo were confused, says Nickel. "They wanted to know if we perhaps had made a mistake. They wanted to continue to feel as good as they did." Nickel believes the findings have important implications for both doctors and patients. "As physicians, we stop many medications because the patient feels a little nauseated, tired, dizzy, and we think it might be related to the drug. So we stop it and the patient gets better. Was that a real drug effect, (or a placebo effect)?" The study results were announced at the annual scientific meeting of the American Urological Association in New Orleans.